IndraLab

Statements


| 2

sparser
"Instead, we find that steatohepatitis in OTULIN-deficient livers is associated with aberrant mTOR activation, and inhibition of mTOR by rapamycin administration significantly reduces the liver pathology."

sparser
"Treated Otulin ∆hep mice displayed reduced weight gain when compared with vehicle-treated mice and even rapamycin-treated controls (Fig.  xref ), demonstrating a pharmacogenetic interaction between OTULIN deficiency and mTOR inhibition."